Capstone Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 500,000 shares of BMY stock, worth $28.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

500,000

Previous 224,279 122.94%

Holding current value

$28.9 Million

Previous $9.31 Million 177.81%

% of portfolio

0.09%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $6.11 Million - $7.97 Million	-153,996 Reduced 68.66%	70,283 $3.64 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $7.78 Million - $10.2 Million	193,254 Added 622.9%	224,279 $9.31 Million
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $15.4 Million - $17.5 Million	-321,271 Reduced 91.19%	31,025 $1.68 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $4.71 Million - $5.62 Million	97,184 Added 38.09%	352,296 $18.1 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $4.71 Million - $5.27 Million	81,437 Added 46.89%	255,112 $14.8 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $4.7 Million - $5.22 Million	73,794 Added 73.88%	173,675 $11.1 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $6.14 Million - $6.96 Million	93,396 Added 1440.19%	99,881 $6.92 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $403,004 - $477,214	5,885 Added 980.83%	6,485 $466,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $78 - $46,104	600 New	600 $43,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $7.57 Million - $8.82 Million	-141,128 Reduced 54.28%	118,893 $7.41 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $14.4 Million - $16.9 Million	244,053 Added 1528.39%	260,021 $15.4 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $555,170 - $629,109	9,615 Added 151.35%	15,968 $990,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $340,103 - $397,614	6,204 Added 4163.76%	6,353 $374,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $413,364 - $539,196	-8,400 Reduced 98.26%	149 $10,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $411,485 - $455,013	-9,222 Reduced 51.89%	8,549 $388,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $514,503 - $613,481	-11,403 Reduced 39.09%	17,771 $848,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $695,073 - $901,343	14,255 Added 95.55%	29,174 $1.52 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $266,015 - $300,045	4,820 Added 47.73%	14,919 $926,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $386,352 - $481,545	7,646 Added 311.7%	10,099 $559,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $146,983 - $169,207	2,453 New	2,453 $155,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Bristol Myers Squibb CO Transaction History